Bayart E et al. |
A major role for mitotic CDC2 kinase inactivation in the establishment of the mitotic DNA damage checkpoint. |
2004 |
Cancer Res. |
pmid:15604258
|
Zhao LY et al. |
An EBF3-mediated transcriptional program that induces cell cycle arrest and apoptosis. |
2006 |
Cancer Res. |
pmid:17018599
|
Noh EJ et al. |
Methyl CpG-binding domain protein 3 mediates cancer-selective cytotoxicity by histone deacetylase inhibitors via differential transcriptional reprogramming in lung cancer cells. |
2005 |
Cancer Res. |
pmid:16357148
|
Shah S et al. |
Targeting pioneering factor and hormone receptor cooperative pathways to suppress tumor progression. |
2012 |
Cancer Res. |
pmid:22258452
|
Setiadi AF et al. |
Epigenetic enhancement of antigen processing and presentation promotes immune recognition of tumors. |
2008 |
Cancer Res. |
pmid:19047136
|
Sharma D et al. |
Restoration of tamoxifen sensitivity in estrogen receptor-negative breast cancer cells: tamoxifen-bound reactivated ER recruits distinctive corepressor complexes. |
2006 |
Cancer Res. |
pmid:16778215
|
Shi J et al. |
Effects of chromatin-modifying agents on CD34+ cells from patients with idiopathic myelofibrosis. |
2007 |
Cancer Res. |
pmid:17616702
|
Brest P et al. |
Histone deacetylase inhibitors promote the tumoricidal effect of HAMLET. |
2007 |
Cancer Res. |
pmid:18056459
|
Su GH et al. |
A novel histone deacetylase inhibitor identified by high-throughput transcriptional screening of a compound library. |
2000 |
Cancer Res. |
pmid:10866300
|
Lin F et al. |
Unique anti-activator protein-1 activity of retinoic acid receptor beta. |
2000 |
Cancer Res. |
pmid:10866321
|
Hsu PY et al. |
Xenoestrogen-induced epigenetic repression of microRNA-9-3 in breast epithelial cells. |
2009 |
Cancer Res. |
pmid:19549897
|
Heller G et al. |
Genome-wide transcriptional response to 5-aza-2'-deoxycytidine and trichostatin a in multiple myeloma cells. |
2008 |
Cancer Res. |
pmid:18172295
|
Allison SJ and Milner J |
Loss of p53 has site-specific effects on histone H3 modification, including serine 10 phosphorylation important for maintenance of ploidy. |
2003 |
Cancer Res. |
pmid:14583461
|
Lin YC et al. |
Statins increase p21 through inhibition of histone deacetylase activity and release of promoter-associated HDAC1/2. |
2008 |
Cancer Res. |
pmid:18381445
|
Ferrara FF et al. |
Histone deacetylase-targeted treatment restores retinoic acid signaling and differentiation in acute myeloid leukemia. |
2001 |
Cancer Res. |
pmid:11196162
|
Nishigaki M et al. |
Discovery of aberrant expression of R-RAS by cancer-linked DNA hypomethylation in gastric cancer using microarrays. |
2005 |
Cancer Res. |
pmid:15781621
|
Bai J et al. |
Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro. |
2005 |
Cancer Res. |
pmid:15781649
|
Rahmani M et al. |
Coadministration of histone deacetylase inhibitors and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERK1/2 inactivation and the generation of ceramide and reactive oxygen species. |
2005 |
Cancer Res. |
pmid:15781658
|
Stiehl DP et al. |
Histone deacetylase inhibitors synergize p300 autoacetylation that regulates its transactivation activity and complex formation. |
2007 |
Cancer Res. |
pmid:17332356
|
Kim M et al. |
LRRC3B, encoding a leucine-rich repeat-containing protein, is a putative tumor suppressor gene in gastric cancer. |
2008 |
Cancer Res. |
pmid:18757430
|
Mori T et al. |
Epigenetic up-regulation of C-C chemokine receptor 7 and C-X-C chemokine receptor 4 expression in melanoma cells. |
2005 |
Cancer Res. |
pmid:15753377
|
Mizutani H et al. |
Romidepsin (FK228), a potent histone deacetylase inhibitor, induces apoptosis through the generation of hydrogen peroxide. |
2010 |
Cancer Sci. |
pmid:20624163
|
Sakuma M et al. |
Promoter methylation status of the Cyclin D2 gene is associated with poor prognosis in human epithelial ovarian cancer. |
2007 |
Cancer Sci. |
pmid:17270028
|
Tomosugi M et al. |
Retinoblastoma gene-independent G1 phase arrest by flavone, phosphatidylinositol 3-kinase inhibitor, and histone deacetylase inhibitor. |
2012 |
Cancer Sci. |
pmid:22957647
|
Chikamatsu K et al. |
Alteration of cancer stem cell-like phenotype by histone deacetylase inhibitors in squamous cell carcinoma of the head and neck. |
2013 |
Cancer Sci. |
pmid:23992541
|
Hattori N et al. |
Methylation silencing of angiopoietin-like 4 in rat and human mammary carcinomas. |
2011 |
Cancer Sci. |
pmid:21489049
|
Sasaki K et al. |
Histone deacetylase inhibitors trichostatin A and valproic acid circumvent apoptosis in human leukemic cells expressing the RUNX1 chimera. |
2008 |
Cancer Sci. |
pmid:18271940
|
Furumai R et al. |
Histone deacetylase inhibitors block nuclear factor-κB-dependent transcription by interfering with RNA polymerase II recruitment. |
2011 |
Cancer Sci. |
pmid:21299717
|
Yamada Y et al. |
Aberrant methylation of the vascular endothelial growth factor receptor-1 gene in prostate cancer. |
2003 |
Cancer Sci. |
pmid:12824880
|
Okada T et al. |
Identification of genes specifically methylated in Epstein-Barr virus-associated gastric carcinomas. |
2013 |
Cancer Sci. |
pmid:23829175
|
Akao Y et al. |
Downregulation of microRNAs-143 and -145 in B-cell malignancies. |
2007 |
Cancer Sci. |
pmid:17892514
|
Leng SL et al. |
Insulin-like growth factor-II renders LIM 2405 human colon cancer cells resistant to butyrate-induced apoptosis: a potential mechanism for colon cancer cell survival in vivo. |
2001 |
Carcinogenesis |
pmid:11577001
|
Ma J et al. |
Promoter hypermethylation and histone hypoacetylation contribute to pancreatic-duodenal homeobox 1 silencing in gastric cancer. |
2010 |
Carcinogenesis |
pmid:20622005
|
Kim YH et al. |
Sodium butyrate sensitizes TRAIL-mediated apoptosis by induction of transcription from the DR5 gene promoter through Sp1 sites in colon cancer cells. |
2004 |
Carcinogenesis |
pmid:15142888
|
Gastaldi T et al. |
Plakoglobin is differentially expressed in alveolar and embryonal rhabdomyosarcoma and is regulated by DNA methylation and histone acetylation. |
2006 |
Carcinogenesis |
pmid:16537559
|
Grassi G et al. |
Inhibitors of DNA methylation and histone deacetylation activate cytomegalovirus promoter-controlled reporter gene expression in human glioblastoma cell line U87. |
2003 |
Carcinogenesis |
pmid:12869421
|
Kwon O et al. |
NF-kappaB inhibition increases chemosensitivity to trichostatin A-induced cell death of Ki-Ras-transformed human prostate epithelial cells. |
2006 |
Carcinogenesis |
pmid:16774937
|
Chen CQ et al. |
Pure curcumin increases the expression of SOCS1 and SOCS3 in myeloproliferative neoplasms through suppressing class I histone deacetylases. |
2013 |
Carcinogenesis |
pmid:23430957
|
Thakur VS et al. |
Green tea polyphenols causes cell cycle arrest and apoptosis in prostate cancer cells by suppressing class I histone deacetylases. |
2012 |
Carcinogenesis |
pmid:22114073
|
Sharma A et al. |
Trichostatin-A modulates claudin-1 mRNA stability through the modulation of Hu antigen R and tristetraprolin in colon cancer cells. |
2013 |
Carcinogenesis |
pmid:23880304
|
Derks S et al. |
Promoter CpG island hypermethylation- and H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer (DCC) gene in colorectal carcinogenesis without affecting neighboring genes on chromosomal region 18q21. |
2009 |
Carcinogenesis |
pmid:19329758
|
Jensen TJ et al. |
Epigenetic remodeling during arsenical-induced malignant transformation. |
2008 |
Carcinogenesis |
pmid:18448484
|
Bhakat KK and Mitra S |
CpG methylation-dependent repression of the human O6-methylguanine-DNA methyltransferase gene linked to chromatin structure alteration. |
2003 |
Carcinogenesis |
pmid:12807730
|
Xiang N et al. |
Selenite reactivates silenced genes by modifying DNA methylation and histones in prostate cancer cells. |
2008 |
Carcinogenesis |
pmid:18676679
|
Nandakumar V et al. |
(-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells. |
2011 |
Carcinogenesis |
pmid:21209038
|
Liu T et al. |
Regulation of Cdx2 expression by promoter methylation, and effects of Cdx2 transfection on morphology and gene expression of human esophageal epithelial cells. |
2007 |
Carcinogenesis |
pmid:16990345
|
Kamitani H et al. |
Expression of 15-lipoxygenase-1 is regulated by histone acetylation in human colorectal carcinoma. |
2001 |
Carcinogenesis |
pmid:11159758
|
Becker JR et al. |
In vivo natriuretic peptide reporter assay identifies chemical modifiers of hypertrophic cardiomyopathy signalling. |
2012 |
Cardiovasc. Res. |
pmid:22198505
|
Song S et al. |
Trichostatin A enhances proliferation and migration of vascular smooth muscle cells by downregulating thioredoxin 1. |
2010 |
Cardiovasc. Res. |
pmid:19633316
|
Zhao TC et al. |
Inhibition of histone deacetylases triggers pharmacologic preconditioning effects against myocardial ischemic injury. |
2007 |
Cardiovasc. Res. |
pmid:17884027
|